Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
89 GBX | 0.00% |
|
+1.71% | +15.58% |
Jun. 04 | EARNINGS AND TRADING: Hummingbird loss narrows as revenue climbs | AN |
Jun. 04 | Crystal Amber's Portfolio Company Wins US Regulatory Nod for Diabetes Device Study Amendment | MT |
Sales 2022 | 6.76M 8.6M | Sales 2023 | -2.14M -2.72M | Capitalization | 52.02M 66.22M |
---|---|---|---|---|---|
Net income 2022 | 8M 10.18M | Net income 2023 | -5M -6.36M | EV / Sales 2022 | -3.67 x |
Net cash position 2022 | 121M 154M | Net cash position 2023 | 82.11M 105M | EV / Sales 2023 | 14.1 x |
P/E ratio 2022 |
11
x | P/E ratio 2023 |
-9.33
x | Employees | - |
Yield 2022 |
17.3% | Yield 2023 |
56% | Free-Float | 80.17% |
1 week | +1.71% | ||
Current month | +1.42% | ||
1 month | +14.84% | ||
3 months | +9.20% | ||
6 months | +32.84% | ||
Current year | +15.58% |
![Extreme 86.12](/images/extremecours_fleche.png)
![Extreme 76.1](/images/extremecours_fleche.png)
![Extreme 71](/images/extremecours_fleche.png)
![Extreme 60](/images/extremecours_fleche.png)
![Extreme 60](/images/extremecours_fleche.png)
![Extreme 50.8656](/images/extremecours_fleche.png)
![Extreme 50.8656](/images/extremecours_fleche.png)
Members of the board | Title | Age | Since |
---|---|---|---|
Chris Waldron
CHM | Chairman | 59 | 14-06-30 |
Director/Board Member | 50 | 17-12-05 | |
Jane Maitre
BRD | Director/Board Member | 63 | 17-05-07 |
Date | Price | Change | Volume |
---|---|---|---|
24-06-10 | 89 | 0.00% | 24 585 |
24-06-07 | 89 | -0.56% | 23,283 |
24-06-06 | 89.5 | -5.79% | 89,072 |
24-06-05 | 95 | +5.56% | 335,468 |
24-06-04 | 90 | +2.86% | 10,688 |
Delayed Quote London S.E., June 10, 2024 at 11:35 am EDT
More quotes1st Jan change | Capi. | |
---|---|---|
+15.58% | 82.62M | |
+7.54% | 13.23B | |
+16.59% | 9.88B | |
+3.63% | 5.77B | |
+8.13% | 5.31B | |
+24.01% | 4.78B | |
-6.40% | 4.62B | |
+19.67% | 4.47B | |
+1.53% | 4B | |
+3.58% | 3.98B |
- Stock Market
- Equities
- CRS Stock